A US judge condemns Monsanto to pay 2,000 million to a couple ill with cancer: Bayer suffers a millionaire judicial defeat . A jury has condemned Monday Monsanto , bought by the German company in 2018, to pay 2.055 billion dollars to a couple who allegedly would have contracted cancer to use the Roundup herbicide.
A US judge condemns Monsanto to pay 2,000 million to a couple ill with cancer
The verdict of the jury of northern California accuses the agrochemical industry of not warning of the dangers of its product, which accumulates more than 13,000 lawsuits for the same reason.
This is the third legal battle lost by the company , but by far the most expensive. The sentence comes when the shareholders of the pharmaceutical giant have refused to support the management of Bayer in the last year and drives the fall of shares in the market.
Alva and Alberta Pilliod, 70, were diagnosed with non-Hodgkins lymphoma four years apart: one in 2011 and another in 2015. The couple used Roundup, a product made with glyphosate, for 35 years on a lot in San Francisco . Both are currently in remission.
The indemnity to be paid by Bayer includes, in addition to the 2,000 million dollars in punitive damages, another 55 million in compensatory damages.
The figure may decrease once the company appeals the judge’s decision. The German chemical giant and pharmacist communicated his disappointment with the verdict and said that the litigation “will take some time before it ends”, since the appeals are pending and that “it will continue to evaluate and refine its legal strategies as it advances in the next phase”.
As in the previous episodes, where Roundup has been blamed for having been a substantial factor in cancer patients, there was a battle on both sides with scientific studies and experts.
According to European and US regulators, it has not been proven that glyphosate can cause cancer. For its part, the World Health Organization (WHO) said in 2015 that “probably” was carcinogenic. A key tool for thousands of plaintiffs.
In this particular case, the company’s lawyers, in addition to backing up on scientific documents, highlighted the family background of the Pilliod who also suffered from cancer and autoimmune diseases that, according to their argument, increased the risk of the couple developing a lymphoma. No-Hodgkins.
Roundup, the flagship product of the Monsanto manufacturer, continues to be sold without a label that warns of carcinogenic risk to humans. Glyphosate is the most used herbicide in the agricultural world and has circulated on the market since 1976.
People familiar with the German company say that there are no plans to make changes before at least one of the cases have been appealed, according to The Wall. Street Journal.
The partners of the company rejected last month the measures taken by senior management, including the purchase of Monsanto. Since then, the papers of the German have fallen 40%.